Navigation Links
American Cancer Society awards 143 research grants to investigators at 83 institutions nationwide
Date:4/24/2009

get for treatment of acute myeloid leukemia (AML), a devastating cancer of the white blood cells with few therapeutic options available. She will test a drug candidate, R788, for safety and activity prior to consideration for analysis in humans.

  • Siddharth Balachandran, Ph.D., Fox Chase Cancer Center, has discovered how to make cells that have become resistant to interferons regain drug sensitivity by eliminating two proteins. Blocking the activity of these proteins could dramatically improve the therapeutic benefit of interferon in a broad range of cancer patients.

  • Charles Cobbs, M.D., California Pacific Medical Center, is testing the novel hypothesis that infection of cancer stem cells by human cytomegalovirus (HCMV) leads to the development of brain cancer. If true, currently available antiviral drugs or vaccines might be effective in the prevention and treatment of brain cancer.

    Clinical Cancer Research and Immunology

    • Irene Georgakoudi Ph.D., Tufts University, is focused on developing non-invasive, optical imaging methods that could enable improved cancer detection by finding abnormal cells in the uppermost layer of tissue that covers the body cavities and organs. If cancerous changes are detected when they are confined to this superficial layer, they could be treated more effectively.

    • Wei-Qun Ding, Ph.D., University of Oklahoma Health Sciences Center, will explore anticancer activity of docosahexaenoic acid (DHA), which is found in fish oil. Dr. Ding has found that DHA inactivates an enzyme that is important for the growth of tumor cells, and this grant will further the understanding of DHA's anticancer activity and provide a biological basis for the development of novel strategies in cancer prevention and therapy using DHA.

    • Jun Yan, M.D, Ph.D., University of Louisville, is developing novel ways to induce immune responses against breast cancer which would lead to
      '/>"/>

    Contact: David Sampson
    david.sampson@cancer.org
    American Cancer Society
    Source:Eurekalert

    Page: 1 2 3 4 5 6

    Related medicine news :

    1. Tips from the American Journal of Pathology
    2. Americans United for Life Disappointed by Oklahoma Governors Veto of Bill Banning Destructive Embryo Research
    3. The 2009 Survey of Americans on HIV/AIDS: Implications for the Domestic HIV/AIDS Crisis
    4. Survey shows Americans may be missing direct route to head and neck cancer care
    5. American Heart Association Web Site Now Offers Content Translated Into Traditional Chinese
    6. American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety
    7. Prime Sponsors at 2009 American Heart Walk
    8. Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
    9. Americans United for Life Condemns FDA Decision that Will Increase Minors Access to Plan B
    10. American Association for Homecare Applauds Senate Subcommittee Efforts to Prevent Waste and Fraud in Medicare; Association Presents 13-Point Legislative Plan to Stop Waste and Fraud
    11. More Americans Experiencing Gaps in Health Coverage
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... have found a novel approach to treating cancer - ... edition of Science Translational Medicine shows that ... sent by nerves that are linked to cancer stem ... of Botox made the treatment cheap, safe and efficient. ... mice, and will soon start testing on humans. , ...
    (Date:8/20/2014)... 2014 Quincy Bioscience, a Wisconsin-based biotech ... of the fastest growing private companies in the ... No. 2,941, Quincy Bioscience is honored again to be ... States. , Quincy Bioscience is manufacturer of Prevagen brand ... protein originally discovered in jellyfish and clinically shown to ...
    (Date:8/20/2014)... DALLAS (PRWEB) August 20, 2014 Caddis ... track records of any healthcare real estate company in ... of medical assets valued at $500 million, including more ... of that significant growth, including expansions into new geographic ... expanded capabilities, company executives are pleased to announce an ...
    (Date:8/20/2014)... (PRWEB) August 20, 2014 Braverman Eye ... the help of their experienced surgeons trained in PresbyLasik. ... to regain their lost or inaccurate vision. Their diligent ... Lasik surgery is making it possible for Presbyopia patients ... which occurs normally in people in the age group ...
    (Date:8/20/2014)... August 20, 2014 Texas Medical Research Associates ... The study will help test the effectiveness of a new ... high cholesterol may be eligible to participate in the study. ... in the blood can lead to cardiovascular disease, the no. ... can help reduce the risk of heart disease and stroke. ...
    Breaking Medicine News(10 mins):Health News:Treating gastric cancer -- with Botox 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2Health News:Texas Medical Research Associates Announce New Study 2
    ... Jenifer Goodwin HealthDay Reporter , TUESDAY, June ... U.S. Preventive Services Task Force recommendations that women in ... and furious. Using email, social networking sites and electronic ... , Researchers say the magnitude of the reaction heralded ...
    ... have discovered a potent and highly-debilitating toxin in the ... is now prompting investigations of other marine mammals in ... by marine algae common on coral reefs, and accumulates ... the human disease caused by ciguatoxin, affects thousands of ...
    ... of Technology & Innovation, Proceedings of the National ... future and enormous need for stem cell therapeutics that ... deadly diseases. http://www.ingentaconnect.com/content/cog/ti/2011/00000013/00000001 ... replacement" procedures to restructure damaged organs, tissues and cells, ...
    ... IN THE ICU , Intensive care units are ... the future. A recent study, conducted by physicians from ... in New York, NY, studying 590 daytime admissions in ... can help address these staff shortages. In the ...
    ... consume an average of 13 hours of media content a ... according to a Northwestern University report, the first national study ... ethnicity. "In the past decade, the gap between minority ... and quadrupled for Hispanics," says Northwestern Professor Ellen Wartella, who ...
    ... Cincinnati (UC) Department of Emergency Medicine has received a ... to study the implementation of electronic health records in ... support the work of Michael Ward, MD, an assistant ... the past year focusing on simulation modeling in operations ...
    Cached Medicine News:Health News:Is Social Networking Changing the Face of Medicine? 2Health News:Is Social Networking Changing the Face of Medicine? 3Health News:The future of stem cell applications challenging, bright 2Health News:Chest journal news briefs -- June 2011 issue 2Health News:Study: Stark differences in media use between minority and white youth 2Health News:Study: Stark differences in media use between minority and white youth 3Health News:Study: Stark differences in media use between minority and white youth 4Health News:Using simulation to model the implementation of electronic health records 2
    (Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
    (Date:8/20/2014)... 2014 Trovagene, Inc. (NASDAQ:   TROV), a ... from two clinical studies will be presented at the ... diagnostic test for the detection of high risk strains ... to take place in Seattle ... Additionally, a new U.S. patent was issued earlier this ...
    (Date:8/20/2014)... , August 20, 2014 ... Conducted in the US  KalVista Pharmaceuticals ("KalVista"), ... edema (DME), today announces that it has begun a ... plasma kallikrein inhibitor, KVD001, for the treatment of DME. ... of the Beetham Eye Institute, Joslin Diabetes Center; Harvard ...
    Breaking Medicine Technology:Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
    ... announces that a new market research report is ... Degeneration Therapy Area Pipeline Report ... Therapy Area Pipeline Report contains detailed information on ... insight into the pipeline status of macular degeneration ...
    ... Allscripts (NASDAQ: MDRX ) announced today that it ... March 31, 2011 after the stock market closes on Thursday, ... and webcast to discuss the company,s earnings and other information ... (Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) More ...
    Cached Medicine Technology:Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 2Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 3Allscripts to Announce First Quarter 2011 Financial Results on May 5, 2011 2Allscripts to Announce First Quarter 2011 Financial Results on May 5, 2011 3Allscripts to Announce First Quarter 2011 Financial Results on May 5, 2011 4
    Sabre 180 is a powerful niche generator....
    The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
    The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
    Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
    Medicine Products: